Dartmouth College

Dartmouth Digital Commons
Dartmouth Scholarship

Faculty Work

9-25-2014

Myeloid Derived Hypoxia Inducible Factor 1-alpha is Required for
Protection against Pulmonary Aspergillus Fumigatus Infection
Kelly M. Shepardson
Dartmouth College

Anupam Jhingran
Memorial Sloan-Kettering Cancer Center

Alayna Caffrey
Montana State University

Joshua J. Obar
Montana State University

Benjamin T. Suratt
University of Vermont

See next page for additional authors
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Genetics and Genomics Commons, and the Medicine and Health Sciences Commons

Dartmouth Digital Commons Citation
Shepardson, Kelly M.; Jhingran, Anupam; Caffrey, Alayna; Obar, Joshua J.; Suratt, Benjamin T.; Berwin,
Brent L.; Hohl, Tobias M.; and Cramer, Robert A., "Myeloid Derived Hypoxia Inducible Factor 1-alpha is
Required for Protection against Pulmonary Aspergillus Fumigatus Infection" (2014). Dartmouth
Scholarship. 2958.
https://digitalcommons.dartmouth.edu/facoa/2958

This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has
been accepted for inclusion in Dartmouth Scholarship by an authorized administrator of Dartmouth Digital
Commons. For more information, please contact dartmouthdigitalcommons@groups.dartmouth.edu.

Authors
Kelly M. Shepardson, Anupam Jhingran, Alayna Caffrey, Joshua J. Obar, Benjamin T. Suratt, Brent L.
Berwin, Tobias M. Hohl, and Robert A. Cramer

This article is available at Dartmouth Digital Commons: https://digitalcommons.dartmouth.edu/facoa/2958

Myeloid Derived Hypoxia Inducible Factor 1-alpha Is
Required for Protection against Pulmonary Aspergillus
fumigatus Infection
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Abstract
Hypoxia inducible factor 1a (HIF1a) is the mammalian transcriptional factor that controls metabolism, survival, and innate
immunity in response to inflammation and low oxygen. Previous work established that generation of hypoxic
microenvironments occurs within the lung during infection with the human fungal pathogen Aspergillus fumigatus. Here
we demonstrate that A. fumigatus stabilizes HIF1a protein early after pulmonary challenge that is inhibited by treatment of
mice with the steroid triamcinolone. Utilizing myeloid deficient HIF1a mice, we observed that HIF1a is required for survival
and fungal clearance early following pulmonary challenge with A. fumigatus. Unlike previously reported research with
bacterial pathogens, HIF1a deficient neutrophils and macrophages were surprisingly not defective in fungal conidial killing.
The increase in susceptibility of the myeloid deficient HIF1a mice to A. fumigatus was in part due to decreased early
production of the chemokine CXCL1 (KC) and increased neutrophil apoptosis at the site of infection, resulting in decreased
neutrophil numbers in the lung. Addition of recombinant CXCL1 restored neutrophil survival and numbers, murine survival,
and fungal clearance. These results suggest that there are unique HIF1a mediated mechanisms employed by the host for
protection and defense against fungal pathogen growth and invasion in the lung. Additionally, this work supports the
strategy of exploring HIF1a as a therapeutic target in specific immunosuppressed populations with fungal infections.
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targets and compounds, a complementary and important area of
investigation is discovering therapies that improve host defense in
immunocompromised patients [6].
Host defense to A. fumigatus challenge requires a functioning
innate immune response with a strong dependence on neutrophils
and other innate immune system effector cells, as their deficiency
or defective function is a principal clinical risk factor for IPA [7,8].
The timing and magnitude of neutrophil recruitment is pivotal for
fungal clearance as a small delay in arrival leads to disease
susceptibility [9,10]. The recruitment of neutrophils to the site of
infection requires a calculated interplay between multiple signaling
chemoattractants and receptors that remain to be fully defined in

Introduction
Invasive fungal infections continue to take a toll on human
health with high mortality and morbidity rates and increasing
frequency [1]. The filamentous fungus Aspergillus fumigatus
remains the most common cause of airborne invasive fungal
infections and is the primary causal agent of invasive pulmonary
aspergillosis (IPA) [2]. The persistence of sub-optimal IPA clinical
outcomes is in part due to a less than optimal understanding of the
Aspergillus-host interaction and toxicity associated with current
antifungal drugs [3,4,5]. While much effort for treatment
improvement is focused on identification of new antifungal drug
PLOS Pathogens | www.plospathogens.org
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pathogens, and particularly fungi, is largely unknown. HIF1a is
a heterodimeric protein whose a-subunit is stabilized under
hypoxic conditions and translocated to the nucleus where it
dimerizes with the b-subunit, referred to as the aryl hydrocarbon
receptor nuclear translocator (ARNT, HIF1b) protein [26]. Once
stabilized and in the nucleus, HIF1a binds to hypoxia response
elements (HREs) of target hypoxia response genes including those
involved in the processes of glucose metabolism, hypoxia,
apoptosis, angiogenesis, and erythropoiesis [27]. HIF1a is
regulated by prolyl hydroxylase’s (PHD) through hydroxylation
of its oxygen-dependent degradation domain and directs HIF1a
for ubiquitin-dependent degradation by the von Hippel-Lindau
(vHL) protein when oxygen is present [26,28]. Activation of
HIF1a requires basal levels of NFkB and in turn, NFkB activation
is controlled by hypoxic inactivation of PHDs [29,30]. Moreover,
the activation of NF-kB in normoxia leads to up-regulation of
HIF1a mRNA levels contrary to hypoxia increased protein levels
[30]. This interdependence between HIF1a and NFkB supports a
strong link between innate immunity and metabolism in controlling disease.
HIF1a plays an important role in innate immunity and host
defense as myeloid cells have HIF-dependency for adaptation to
hypoxic and inflamed microenvironments that develop during
infection. For example, HIF1a is critical for regulating bactericidal
activity of phagocytes against Group B Streptococcus [31]. In other
pathogens, such as Group A Streptococcus and Staphylococcus aureus,
presence and induction of HIF1a in myeloid cells, specifically
macrophages and neutrophils, increases phagocytic activity and
controls systemic spread of these pathogens [23,25]. HIF1a has been
suggested to be involved in the suppression of the angiogenic response
by A. fumigatus in murine models of IA [32]. More recently,
pulmonary HIF1a mRNA levels were observed to increase in
response to the human fungal pathogen Coccidioides immitis [33].
Although the roles of HIF1a in myeloid cell bactericidal activity
and inflammatory diseases are established, the function of HIF1a in
the course of lung infections and particularly with fungi remains
unclear. Therefore, we investigated the role of HIF1a following
pulmonary challenge with A. fumigatus using a myeloid-specific
lysozyme-M cre-recombinase driven HIF1a null mouse (HIFC) [22].
We observed that A. fumigatus challenge strongly induces HIF1a
stabilization in wild-type immune competent murine lungs and
macrophages; a process that is inhibited by administration of
corticosteroids. Loss of myeloid HIF1a in otherwise immune
competent mice resulted in a dramatic decrease in murine survival
when challenged with A. fumigatus conidia. Surprisingly, rather than
a role for HIF1a in mediating fungal killing by innate effector cells as
previously observed with bacterial pathogens, the reduction in
murine survival was in part mediated by a reduced number of
neutrophils and innate immune effector cells early following fungal
challenge. Reductions in these innate effector cells in the airways and
lung in the absence of HIF1a were partially due to defective induction
of the chemotactic signal CXCL1. These results support a role for
HIF1a in initiating the correct inflammatory signal and immune
response in order to prevent pulmonary fungal growth. Therefore,
modulation of HIF1a signaling in specific immunocompromised
patient populations is a potential area for therapeutic development.

Author Summary
Due to the limited treatment options and severity of
invasive fungal infections, a better understanding of
fungal-host interactions is needed for the development
of new therapies. Recent studies have implicated a role for
hypoxia inducible factor 1-alpha (HIF1a) in the regulation
of inflammation and host defense responses to microbial
pathogens. In this study, we discover that HIF1a is
required for protection and murine survival to Aspergillus
fumigatus pulmonary challenge. First, we observed that
nuclear HIF1a protein levels are reduced in the murine
corticosteroid immunosuppressed model of invasive pulmonary aspergillosis, suggesting its involvement in disease
outcome. We then tested the hypothesis that HIF1a is
required by innate immune effector cells to control/
prevent A. fumigatus growth and invasion. Surprisingly,
we observed that the role of myeloid HIF1a is not to
mediate innate effector cell A. fumigatus killing directly,
but rather to induce and maintain a protective immune
response that ensures proper effector cell recruitment and
survival at the site of infection. These findings provide a
better understanding of host mechanisms involved in
thwarting fungal pathogenesis, have implications for host
susceptibility, and reveal the potential for novel treatment
strategies involving HIF1a mediated signaling in the lung
in immune suppressed patients.
the context of IPA. Alveolar macrophages, likely the first leukocyte
exposed to conidia within the lung, induce the expression of proinflammatory cytokines, such as TNF, IL-1a/b, IL-6, GM-CSF,
CXCL2, and CXCL1 in response to engagement of fungal
PAMPs by macrophage PRRs such as toll-like receptors (TLRs)
and dectin-1 [11,12,13]. Whether through MyD88-dependent or –
independent signaling, the expression of these cytokines is
mediated through the transcription factors NFkB, NFAT, and
IRF’s and are indispensible for proper clearance and preventing
invasive disease [12]. In particular, the CXC chemokines defined
by the amino acid sequence Glu-Leu-Arg (ELR) preceding the
CXC motif, macrophage inflammatory protein 2 (MIP-2, murine
CXCL2) and keratinocyte-derived chemokine (KC, murine
CXCL1) are pivotal factors for neutrophil migration [14].
Neutrophils sense and respond to these inflammatory signals
through surface expressed G-protein coupled receptors, cytokine
receptors, adhesions (selectins and integrins), Fc-receptors, and
innate receptors (TLRs and C-type lectins) [15]. Classical
chemoattractant receptors expressed on the surface of neutrophils,
including leukotriene B4, platelet-activating factor, and CXCR1
and CXCR2 are required for neutrophil recruitment and
migration; mice deficient in these receptors are more susceptible
to IPA [10,16,17,18]. Once recruited to the lung and upon contact
with hyphae, neutrophils induce degranulation, the respiratory
burst, proteases, and antimicrobial peptides leading to both
pathogen and host damage [9,19,20,21]. The precise molecular
mechanisms involved in neutrophil lung recruitment in response to
A. fumigatus infection remain to be fully defined.
Pathogen driven inflammation and necrosis of tissue leads to
development of microenvironments deficient in oxygen and
nutrients, but there is a lack of knowledge regarding how host
and pathogen responses to these deficiencies affect the outcome of
pathogenesis [21]. Studies have implicated a role for hypoxia
inducible factor 1 (HIF1a), a major regulator of the mammalian
response to hypoxia, in the regulation of inflammation and host
defense responses to microbial pathogens [22,23,24,25]. However,
the role of HIF1a in immune responses to lung microbial
PLOS Pathogens | www.plospathogens.org
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Corticosteroid treatment reduces HIF mRNA abundance
and protein nuclear localization induced by A. fumigatus
pulmonary challenge
To determine whether HIF1a stabilization is part of the
pulmonary innate defense response to pathogenic fungi, levels of
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mice were also observed, which has been reported previously,
validating the chosen murine model (Figure 1B–C) [37,38].
These results suggest that reductions in HIF1a nuclear levels
may contribute to susceptibility of corticosteroid treated mice to
A. fumigatus.

HIF1a mRNA abundance and protein were analyzed in an
immune competent murine model of fungal bronchopneumonia
initiated by A. fumigatus challenge. Consistent with a potential
role for HIF1a in defense against pulmonary fungal disease, A.
fumigatus induced a three-fold increase in HIF1a mRNA
abundance in the lung compared to PBS inoculated controls
(Figure 1A). Accordingly, stabilization of HIF1a protein and
increased nuclear localization occurred in murine lungs exposed to
A. fumigatus conidia with greater HIF1a protein levels occurring
in the cytoplasmic fraction of the PBS inoculated mice (Figure 1B).
These results demonstrate two distinct effects of A. fumigatus
challenge on HIF1a in the murine lung, the increase of HIF1a
mRNA and an increase in nuclear HIF1a protein localization. In
addition, HIF1a stabilization occurs in vitro with cultured
macrophages exposed to A. fumigatus conidia and germlings in
standard tissue culture conditions (Figure S1A). Taken together, in
a healthy immune competent murine lung, HIF1a is stabilized in
response to A. fumigatus pulmonary challenge, suggesting an
important role for this protein in resistance to pulmonary fungal
growth and subsequent infection.
Consequently, we next sought to determine whether activation
of HIF1a was inhibited under conditions known to enhance
susceptibility to A. fumigatus pulmonary growth and infection.
We determined the effects of corticosteroids on HIF1a stabilization in response to A. fumigatus [34]. Although the effect of
steroids on host immune cells has been focused on the role of
NFkB, recently, the glucocorticoid dexamethasone was found to
abrogate the activation of HIF1a in response to inflammation
induced hypoxia [35,36]. Intriguingly, corticosteroid treatment of
mice significantly reduced mRNA induction of HIF1a two-fold
when exposed to conidia of A. fumigatus (Figure 1A). Corticosteroid treatment also resulted in decreased levels of HIF1a
protein with overall reduced levels in nuclear extracts in both A.
fumigatus inoculated and uninoculated mice compared to
immune competent mice (Figure 1B–C). Reductions in nuclear
levels of the p65 subunit of NFkB in the corticosteroid treated

Myeloid HIF1a is required for survival and clearance
following A. fumigatus pulmonary challenge
To delineate the function of HIF1a in pulmonary host
defense to A. fumigatus, we utilized a conditional knockout
system to strongly reduce HIF1a levels in the myeloid
compartment [22]. The conditional mice (HIFC) expressed
Cre recombinase under the control of the lysozyme M promoter
in combination with the loxP flanked exon2 of the HIF1a gene.
HIF1a levels were significantly reduced in myeloid derived cells,
especially macrophages and neutrophils (Figure S1B) [22].
Immune competent mice deficient in myeloid HIF1a (HIFC)
were strikingly more susceptible to A. fumigatus pulmonary
challenge compared to littermate controls, with 100% mortality
occurring in HIFC mice by day 3 of the experiment and
statistically different mortality by day 2 post- fungal inoculation
(p = 0.0007) (Figure 2A, p,0.0001). HIFC mice had increased
fungal burden at 24 and 48 hrs post inoculation compared to
littermate controls that began clearing the conidial inoculum
after 24 hrs as measured by quantitative real-time PCR analysis
of the fungal 18S rDNA gene (Figure 2B) [39]. Dissemination to
the liver and kidney was also increased in HIFC mice (data not
shown).
Histopathology of the lungs 8 hrs post-fungal inoculation
revealed no apparent difference in the number of conidia in the
lungs of HIFC and littermate control mice (Figure S2A). However,
decreased levels of cellular infiltrate and inflammation were
apparent in HIFC mice A. fumigatus challenged mice (Figure
S2A), and this phenotype was also observed at 12 hrs post
inoculation (Figure 2C–D). However, the difference in the cellular
infiltrate and inflammation was dramatically greater in the

Figure 1. Steroid treatment reduces HIF mRNA abundance and protein nuclear localization induced by A. fumigatus infection. CD-1
mice were treated with triamcinolone (TC) or PBS (Treatment) 1 day prior to fungal inoculation. Mice were inoculated with either 76107 conidia or
PBS i.t. (infection type) and lungs were collected for analysis at 24 hrs. A) mRNA abundance of HIF1a from the whole lung was analyzed by
quantitative-RT-PCR. Combined 4 biological and 3 technical replicates for each transcript, using hprt as the housekeeping gene for normalization.
Fold change is relative to one PBS, PBS biological replicate. B) Protein abundance of HIF1a and NFkB p65 subunit in the cytoplasmic and nuclear
extracts from the whole lung were analyzed by Western Blot. Representative blot of two biological experiments shown. C) Quantitation of the band
densities for HIF and p65 following normalization to c-tubulin (c-tub). Representative of two biological replicates with fold change relative to the PBS,
PBS sample. * indicates a P value of ,0.03 and # indicates a P value of 0.05 (unpaired two-tailed Students t test).
doi:10.1371/journal.ppat.1004378.g001

PLOS Pathogens | www.plospathogens.org
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Figure 2. Myeloid HIF1a is required for fungal clearance and survival following A. fumigatus pulmonary challenge. Immune competent
littermate (Cre-/HIF1a floxed: WT) and HIFC mice received 76107 conidia i.t. and were A) monitored for survival (Log-Rank Test, # = p,0.0001,
repeated twice) and B) Fungal burden on days 1 and 2 post challenge. Data represent 5 biological and 3 technical replicates for each time point.
Representative histology of H&E or GMS stained lung sections from C) HIFC and D) WT mice at 12 and 24 hr post challenge. Left image (56), right
image (206). Levels of E) Albumin and F) LDH were measured in the BALFs at 4, 8, 12, and 24 (LDH) hrs of WT and HIFC mice challenged with 76107
conidia (Af) or PBS (4–8 biological replicates for each time point). * indicates P value of ,0.02, ** indicates P value of ,0.05 (unpaired Students t test).
doi:10.1371/journal.ppat.1004378.g002

Susceptibility of HIFC mice is not due to a defect in
uptake or killing by pulmonary myeloid effector cells

littermate controls at 12 hrs post inoculation consistent with a selfresolving fungal bronchopneumonia in these immune competent
mice. At later time points post fungal inoculation, 24 and 48 hrs,
littermate control mice were able to clear and contain the infection
with mostly fungal debris remaining in the lung at 48 hrs
(Figure 2C–D & Figure S2B), while the HIFC mice develop invasive
disease with uncontrolled hyphal growth. Additionally, the HIFC
mice develop increased levels of pulmonary damage, with
significantly more lactate dehydrogenase (LDH) apparent in
bronchoalveolar lavage fluid (BALF) at 24 hrs post challenge, but
with no marked differences in vascular leakage determined by
albumin BALF levels (Figure 2E–F). These results suggest that there
is a defect in the innate immune response early during the response
to A. fumigatus challenge in the HIFC mice that renders them
unable to clear and prevent fungal growth and host tissue damage.
PLOS Pathogens | www.plospathogens.org

Previous reports on HIF1a’s function during bacterial infection
determined the importance of its activation and presence for
neutrophil and macrophage-mediated pathogen killing [22,23,25].
We therefore sought to determine if the susceptibility of the HIFC
mice to A. fumigatus challenge was due to an overall defect in
innate effector cell mediated fungal killing. First, utilizing ex vivo
bone marrow derived macrophages (BMDMs) from HIFC and
littermate control mice, no difference in the ability of these cells to
phagocytose conidia was observed between genotypes (Figure 3A).
Additionally, there was no difference in the BMDM’s ability to
cause damage to phagocytosed conidia as measured by overall
metabolic activity of the conidia phagocytosed by the BMDMs
(Figure 3B).
4
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Figure 3. HIF1a is not required for phagocytic uptake or killing of A. fumigatus by macrophages, monocytes, and neutrophils.
BMDMs (A,B) and BMDNs (C,D) from littermate (WT) and HIFC mice were incubated with germlings (A,B) or FLARE conidia (C,D) in a 9:1 ratio for 3 hrs
and CFU (A), Damage by XTT (B), or Uptake (C) and Killing (D) by FACs analysis. Uptake and killing in vivo of FLARE conidia by neutrophils
(lung,E:BALF,F) and monocytes (G) 12 hrs following challenge with 36107 FLARE conidia. Uptake bars represent both live and dead conidia engulfed
and live bars represent only engulfed live conidia by the specific cells. Shown are cumulative data from three independent studies. The data are
expressed as plus SEM. * indicates P value of ,0.02 (unpaired two-tailed Students t test).
doi:10.1371/journal.ppat.1004378.g003

To confirm these results in vivo in the context of appropriate
inflammatory cues needed for full activation of innate effector
cells, we generated a fluorescent Aspergillus reporter (FLARE)
strain in the CBS144.89 (CEA10) wild-type background through
ectopic insertion of TdTomato driven by the A. nidulans gpdA
promoter. A single ectopic insertion of the construct by Southern
blotting and FLARE based viability were confirmed as previously
reported for the AF293 FLARE strain (Figure S3) [40]. A.
fumigatus FLARE conidia contain two fluorophores that allow
leukocytes to be distinguished based on their ability to engulf and/
or kill conidia. The TdTomato fluorescence expressed by the
conidia is lost upon conidia death, whereas the other fluorophore
(AF633 or BV421) coating the conidia is stable even at low pH
allowing for tracking of the conidia within leukocytes, whether
dead or alive. Utilizing the FLARE strain, which allows real time
measurement of conidial uptake and viability ex vivo and in vivo,
we observed that HIF1a was not required in bone marrow derived
neutrophil (BMDN) mediated uptake and killing of A. fumigatus
conidia (Figure 3C–D) [40].
In agreement with ex vivo observations with single cell types
derived from the bone marrow, inoculation of the FLARE strain into
the immune competent murine model also revealed no significant
difference in the ability of neutrophils or monocytes to engulf or kill
conidia (Figure 3E–G). These surprising results demonstrate that
HIF1a is not required for innate effector cell mediated killing
following challenge with a fungal pathogen, which is in contrast to
what has been determined with bacterial pathogens ex vivo and in
skin models where HIF1a is critical for bactericidal activity of these
effector cells [23,25]. These results suggest unique HIF1a mediated
PLOS Pathogens | www.plospathogens.org

mechanisms are employed by the host for protection and defense
against fungal pathogen growth and invasion in the lung.

HIFC mice have decreased numbers of lung neutrophils
early during infection
One factor determining the outcome of A. fumigatus lung
infection is the timing and recruitment of neutrophils into the lung
[8,9,41]. Due to the decrease in inflammation observed in the
histology of the HIFC A. fumigatus challenged mice, we
quantitatively analyzed the level of innate effector cells through
analysis of BALF and lung cellularity at early time points following
fungal challenge. Consistent with the qualitative histopathology
observations, the overall BALF and lung cellular infiltrates of
inoculated littermate mice was greater than the HIFC mice at all
time points examined (Figure 4). At 4 and 8 hrs post fungal
inoculation littermate mice displayed higher numbers of monocyte-like cells (CD11b+Ly6G2) and macrophages (CD11c+) in the
BALF and at 8 hrs within the lung (Figure 4B–C,E). Interestingly,
HIFC mock treated mice tended to have modestly higher levels of
macrophages than littermate controls, though not always statistically significant (Figure 4C,E). More importantly, the main innate
effector cells known to be required for clearance and defense
against A. fumigatus, neutrophils and inflammatory monocyte-like
cells, were consistently ,2–3 fold lower in HIFC mice following
fungal challenge at 4, 8 and 12 hrs in the BALF and at 8 hrs in the
lung (Figure 4A,E p,0.02). These data suggest that HIFC mice
are defective in overall effector cell population numbers early
following fungal challenge in the lung and that this may contribute
to their inability to control fungal growth and tissue damage.
5
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Figure 4. Mice deficient in myeloid HIF1a have significantly less neutrophils in BALF and lung tissue early during lung infection.
FACs analysis of cell recruitment at 4, 8, and 12 hrs post challenge using CD11b, Ly6G, and CD11c fluorescent antibodies for staining of cells in the
BALF (A, B, C, D) or lung (E, 8 hrs only) of littermate (WT) and HIFC mice inoculated with 76107 conidia (Af) or PBS. Representative experiment of three
(BALFs) or two (Lung digests) showing N = 4 for inoculated and N = 2 for mock. * indicates a P value of ,0.03 (unpaired Students t test). Neutrophils
are designated as CD11b+Ly6G+ (A and D, gate I, expanded gate I,i). Monocyte-like cells are designated as CD11b+Ly6G2 (B and D, gate I, expanded
gate I,ii). Macrophages are designated as CD11c+ (C and D, gate II). D) Representative FACs plots of WT and HIFC infected mice (Af). Main plots are
CD11b v. CD11c and expanded cell population gate I plot is CD11b v. Ly6G.
doi:10.1371/journal.ppat.1004378.g004

HIFC neutrophils have increased levels of apoptosis

function [43]. Therefore, we sought to determine whether there
was a defect in survival of HIF1a-deficient neutrophils in the
presence and absence of fungal stimulation.
Agreeing with previously reported data [44], we determined
that murine neutrophils deficient in HIF1a have increased cell
death compared to wild-type control neutrophils with HIF1a
deficient neutrophils exhibiting increased apoptosis at 5 hrs and
increased necrosis at 22 hrs in the absence and presence of
stimulation with the fungal b-glucan derivative curdlan (Figure 5A–B). Examination of the cellular infiltrates from BALFs of
mice 8 hrs post A. fumigatus challenge revealed an increase in
apoptotic neutrophils visualized by increased pyknotic nuclei and

Considering that early following fungal challenge there is
precedence for the requirement of neutrophils and inflammatory
monocytes in terms of infection outcome, we next sought to
determine how HIF1a is involved in the neutrophil response
following fungal challenge. During inflammation, the absence of
HIF1a in effector cells is characterized by depletion of ATP stores
due to a failure to switch from oxidative to glycolytic metabolism,
which also results in an increase in toxic levels of ROS [42].
However, neutrophils rely strongly on glycolytic metabolism even
though they have the capacity for aerobic respiration, supporting a
major role for HIF1a in maintenance of normal neutrophil
PLOS Pathogens | www.plospathogens.org
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Figure 5. HIFC neutrophils have increased levels of apoptosis and necrosis and decreased endothelial attachment. Littermate (WT)
and HIFC BMDNs were stimulated with PBS or 100 ug/mL curdlan in TC media for 5 hr (A) or 22 hr (B) and AnnexinV/PI staining was conducted using
FACs (combined two biological replicates). Av+PI+ (necrotic), Av+PI2 (apoptotic), Av2PI2 (normal). C) Percent neutrophils demonstrating pyknotic

PLOS Pathogens | www.plospathogens.org
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or karyorrhexis nuclei and ruffled membranes was determined from cytospins from littermate (WT) and HIFC mice at 8 hr post challenge with 76107
conidia (Af) or PBS. Data represent the mean from 2 independent biological replicates from 4 mice/genotype in each experiment. (D) Representative
images of the cytospins depicting cell phenotypes. Red arrows indicate pyknotic neutrophils, blue arrows indicate neutrophil karyorrhexis, ruffled
neutrophils labeled as ruffled, and black arrow heads designate macrophages. All images = 606. (E) Histology vasculature images displaying
margination of neutrophils at 206. * indicates P value of ,0.05 ** indicates P value of ,0.01 (unpaired Students t test).
doi:10.1371/journal.ppat.1004378.g005

karyorrhexis of HIFC compared to wild-type neutrophils (Figure 5C–D) [45,46,47]. There was no difference in the number of
wild-type and HIFC neutrophils with ruffled membranes, a marker
of neutrophil activation (Figure 5C–D) [48]. These data correlate
with the increase in LDH observed in the HIFC mice (Figure 2F).

production of IL-17 and IL-12p40 between the WT and HIFC
challenged mice (Figure 6F). The overall response in the HIFC
mice at 12 hrs post challenge did not deviate from the usual Th1
protective response with Th2 specific cytokines either unchanged
(IL-10) or undetectable (IL-4, data not shown). The production of
one of the major neutrophil chemotactic cytokines CXCL1 was
decreased in the HIFC inoculated mice compared to littermate
controls early following fungal challenge (Figure 6C). This
reduction in CXCL1 correlated directly with the quantitative
neutrophil defect found during early time points following fungal
challenge (Figure 4A).
HIF1a is directly required for CXCL1 mRNA levels as the
mRNA abundance in response to A. fumigatus is significantly
decreased in macrophages deficient in HIF1a (Figure 6D).
Whether the HIF1a regulation of CXCL1 mRNA levels is at
the transcriptional or post-transcriptional levels remains unclear,
however, analysis of the DNA sequence upstream of the CXCL1
start codon revealed multiple potential HRE elements (Figure
S5A). Importantly, the production of CXCL2 [53] and CXCL5
[54], other neutrophil chemokines detected by CXCR2, was not
different between the WT and HIFC inoculated mice (Figure 6E).
Additionally, no statistically significant difference in the mRNA
abundance of the receptors CXCR2, TLR4, and Dectin-1 were
observed between the WT and HIFC neutrophils (Figure S5B).
Taken together, these results support a direct role for HIF1a in
production of cytokines early in the pulmonary response to A.
fumigatus challenge. They also support the hypothesis that the
neutrophil quantitative BALF defect in the HIFC mice is due in
part to decreased levels of CXCL1 and/or other pro-inflammatory
cytokines.

The defect in pulmonary neutrophil numbers in the HIFC
mice correlates to reduced chemotactic and survival
signals
Previous reports have identified a role for HIF1a in tissue
adhesion, migration and invasion by neutrophils and macrophages
at sites of infection and inflammation [22,49]. In the HIFC mice,
we observed a decrease in the level of margination on the vessel
walls compared to the littermate mice (Figure 5E). Margination is
a prerequisite for neutrophil transendothelial migration (TEM)
from the capillaries into pulmonary tissue [50]. There is much
controversy as to the requirement for selectin-mediated rolling in
order for TEM to occur, but chemokine production due to
stimulation from foreign agents is known to increase margination
and TEM [51,52]. In addition to the lack of margination, the
migration of the inflammatory cells away from the vessels is
minimal in the HIFC mice compared to littermate controls in
which the cells have progressed into the alveoli (Fig. 2). These
results demonstrate a defect in the HIFC neutrophils ability to
sense and migrate towards conidia within the lung environment.
Therefore, we next sought to determine if there was a defect in
neutrophil migration or chemotactic signaling in HIFC mice that
could account for decreased neutrophil numbers in vivo in
response to A. fumigatus challenge. In response to the general
chemotactic signal fetal bovine serum (FBS), HIFC neutrophils
were able to migrate to the same capacity as littermate neutrophils
ex vivo (Figure 6A). Importantly, this assay was conducted within
the time window during which there was no difference in apoptosis
between WT and HIFC neutrophils. Consequently, the migration
results indicated that a defect in the production of chemotactic/
cell survival signals at the infection site or the neutrophil response
to tissue-specific signals may be the cause of reduced PMN
numbers in vivo.
Since HIFC neutrophils were competent to migrate in response
to general chemotactic factors (Figure 6A), we next determined if
there was a defect in the production of chemotactic signals during
fungal pulmonary challenge that would result in decreased
migration or cell survival. Utilizing the BALFs of A. fumigatus
challenged HIFC and littermate mice as the source of chemotactic
factors in the transwell migration assay, we observed that
littermate and HIFC neutrophils were defective in migration
towards the HIFC BALF, but not towards littermate control
BALF. This result indicated there was a missing chemotactic
component in the HIFC but not littermate control BALF
(Figure 6B). These results support a defect in chemotactic or cell
survival signal production in HIFC mice following A. fumigatus
pulmonary challenge.
Cytokine/chemokine analysis of the 12 hr BALFs from A.
fumigatus challenged mice indicated decreased production of the
pro-inflammatory cytokines G-CSF, IL-1a, IL-6, and TNF with
no difference in production of the anti-inflammatory cytokine IL10 (Figure 6F). There was no observed difference in the
PLOS Pathogens | www.plospathogens.org

Neutrophil levels and survival of HIFC mice can be
restored by addition of physiologically relevant amounts
of CXCL1 during early infection
We next sought to determine if the HIFC phenotype was due, at
least in part, to the marked reduction in CXCL1 levels. Mice
deficient in CXCR2 (ligands CXCL1 (KC), CXCL2 (MIP2),
CXCL5 (LIX)) develop invasive aspergillosis resulting from
delayed neutrophil influx that allows conidial germination
[10,55]. Additionally, the transient expression of CXCL1 during
invasive aspergillosis causes an earlier and increased number of
neutrophils in the lung that results in improved host defense and
outcome of Aspergillus infection [55]. In order to define the
involvement of CXCL1 in neutrophil migration, LPS-free
recombinant CXCL1 was added to the BALF of A. fumigatus
challenged HIFC mice to the level that was determined in the
littermate BALF (Figure 6C). The addition of physiological levels
of CXCL1 largely restored the neutrophil migration defect
observed with A. fumigatus challenged HIFC BALF (Figure 7A,
p,0.001).
This significant restoration of neutrophil migration by CXCL1
led us to examine if the addition of recombinant CXCL1 to the
HIFC A. fumigatus challenged mice could restore neutrophil levels
and murine survival. Previously, kinetics of neutrophil recruitment
after 4 hrs by the intratracheal instillation of varying amounts of
CXCL1 to the lung was demonstrated [56]. Doses of 30 ng and
100 ng of CXCL1 were demonstrated to induce ,1.5 and ,3.5
8
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Figure 6. Decreased neutrophil levels in HIFC mice correlates to decreased production of CXCL1 and not migration defects.
Migration of littermate (WT) and HIFC BMDNs in the presence of (A) RPMI media containing FBS or nothing or (B) 12 hr BALF from HIFC or WT mice
inoculated with 76107 conidia (Af) was measured using a 3 mm transwell chamber. (C) In vivo CXCL1 protein was measured in BALFs from 4 and 8 hr
infections using an ELISA from AssayBiotech. (D) WT and HIFC BMDMs were incubated with A. fumigatus conidia in a 10:1 ratio for 8 hrs. mRNA
abundance of cxcl1 was determined using quantitative RT-PCR, normalized to rpl13a, and relative to the HIFC sample (3 biological and 3 technical
replicates). (E) In vivo CXCL2 and CXCL5 protein was measured in BALFs from 8 hr infections. (F) In vivo cytokine protein production was measured in
BALFs from the same model in (B) using a cytokine luminex bead array from BioRad. (C,E) Data represent 3–4 biological replicates and depicted as
mean plus SEM (N.D. = not detectable). * indicates a P value of ,0.03 and ** indicates a P value of ,0.05 (unpaired Students t test).
doi:10.1371/journal.ppat.1004378.g006

apoptosis/necrosis in the HIFC neutrophils, we determined if the
addition of recombinant CXCL1 affected survival of the HIF1a
deficient neutrophils. Adding physiologically relevant levels of
recombinant CXCL1 to the HIFC neutrophils decreased their
time-dependent level of apoptosis and necrosis ex vivo (Figure 7G).
This demonstrates that CXCL1 signaling promotes and restores
HIF1a neutrophil survival providing support for the requirement
of HIF1a-dependent production of CXCL1.

fold increases in neutrophil recruitment over PBS treatment,
respectively [56]. Based on these previously published results, we
utilized a dose of 50 ng recombinant CXCL1 for intratracheal
instillation. The addition of CXCL1 to the HIFC A. fumigatus
challenged mice restored neutrophil numbers in the BALF back to
levels of littermate inoculated mice and this restoration correlated
with a significant increase in murine survival and improved
outcome of infection based on the observed decrease in fungal
burden and tissue damage (Figure 7B–C,E,F). The addition of
CXCL1 also restored the inflammatory monocyte-like levels back
to littermate controls, but not the CD11c+ macrophages, which
was expected, as they are known to not respond to CXCL1
(Figure 7D, & Figure S4). These results demonstrate a unique
requirement and mechanism for HIF1a control and induction of
CXCL1 in response to A. fumigatus challenge in the lung.
Due to the multifunctional role of some cytokines in chemotactic and angiogenic responses and the observed increase in
PLOS Pathogens | www.plospathogens.org

Discussion
In this study, we uncover a novel and essential function for
myeloid HIF1a in protection against pulmonary A. fumigatus
challenge. We present findings that myeloid HIF1a is required for
initiating protective inflammatory signals and responses to control
A. fumigatus growth and host tissue damage. These data strongly
suggest a role for HIF1a in providing host protection to
9
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Figure 7. Restoration of physiologically relevant amounts of CXCL1 during infection restores neutrophil levels and survival of HIFC
mice. (A) BMDNs migration from littermate (WT) and HIFC mice in the presence of 12 hr BALF from HIF, HIF+ 600 pg rCXCL1, and WT mice inoculated
with 76107 conidia was measured using a 3 mm transwell chamber. Immune competent WT and HIFC mice received 76107 conidia (Af) i.t. and were
treated with 50 ng rCXCL1 4 hr post conidial challenge and monitored for (B) survival (p,0.002, 2 experiments: 12 mice total), (C) fungal burden at
36 hrs (4 biological, 3 technical reps), and (D) FACs analysis of BALF cellularity including: CD11b+Ly6G+ neutrophils, CD11b+Ly6G- monocyte-like, and
CD11c+ macrophages, (N = 4 per group, representative of two experiments). Representative histology of H&E and GMS stained sections of the HIFC+
CXCL1 mice (E) at 12 hr and 24 hr and H&E sections of (F) 12 and 24 hr vasculature (206). (G) WT and HIFC BMDNs were stimulated with PBS or 60 pg
rCXCL1 for 22 hrs and AnnexinV/PI staining was conducted using FACs (combined two biological experiments). Av+PI+ (necrotic), Av+PI2
(apoptotic), Av2PI2 (normal).
doi:10.1371/journal.ppat.1004378.g007

BALF albumin measurement), but as infection progresses and
fungal burden increases an increase in the level of damage
occurring in the lung in the absence of HIF1a occurs as evidenced
by the increase in LDH levels. We cannot currently rule out
systemic effects of HIFC loss on murine survival, however, there
was a trend toward increased fungal dissemination to the kidneys
and liver in the HIFC mice that could contribute to the rapid
mortality (data not shown). The increased mortality therefore is
likely due to the combination of the dysregulated host response
and subsequent increased fungal burden following A. fumigatus
challenge.
Perhaps most surprisingly, given previous studies in bacterial
pathosystems, HIF1a was not required for direct killing of A.

pulmonary fungal disease, provides a deeper understanding of the
fungal-host interaction in the lung, identifies a new genetic factor
critical for resistance to pulmonary murine fungal infections, and
argues for further investigation into the therapeutic potential of
HIF1a modulation for fungal disease.
Importantly, our results demonstrate a requirement for myeloid
HIF1a in murine survival to A. fumigatus pulmonary challenge.
The kinetics and final outcome of murine survival in the absence
of myeloid HIF1a is striking. Mortality in HIFC mice does not
appear to be due to an increased inflammatory response as there is
less overall inflammation in the lung at the time points analyzed in
our model. Upon examination of the lung, there appears to be no
gross defects in the vasculature in the HIFC mice (also suggested by
PLOS Pathogens | www.plospathogens.org

10

September 2014 | Volume 10 | Issue 9 | e1004378

HIF1a and Pulmonary Aspergillus Pathogenesis

fumigatus conidia ex vivo or in vivo by innate effector cells. This is
in contrast to the requirement for HIF1a in killing of multiple
gram-negative and –positive bacteria in epidermal wound models
of infection [22,23,25]. As HIFC neutrophils are not defective in
their ability to elicit the respiratory burst [23], it is perhaps not
surprising that no difference in their ability to kill A. fumigatus
conidia was observed due to the known conidial susceptibility to
reactive oxygen species [57,58]. Additionally, we cannot rule out
that the ability to kill conidia may be due to a compensatory
HIF2a mechanism, as it has distinct and overlapping biological
roles with HIF1a [59]. Importantly, these observations demonstrate the plasticity of HIF1a regulation between different tissue
microenvironments and with fungal and bacterial organisms. As
the phenotypes of innate cells differ between tissues within the host
[60], it will be important to determine if the findings presented
here occur with other pathogens such as the bacteria examined in
the epidermal model that are also potent lung pathogens.
Though HIF1a does not seem to regulate innate mediated
killing of A. fumigatus conidia per se, our data suggest a required
role for HIF1a in controlling A. fumigatus infection through
modulation of the infection microenvironment that drives the
timing, recruitment, and survival of neutrophils at early critical
time points following A. fumigatus challenge. Recruitment of
myeloid cells during epidermal inflammation is known to require
HIF1a and is reported to be due to decreased HIF1-dependent
integrin expression [22,49]. This may partially account for the
decreased margination observed in the HIFC mice challenged with
A. fumigatus, however, due to the increased percentage of
neutrophils in the pulmonary capillary blood and the smaller size
of the capillaries, the importance of integrin and selectin binding
for pulmonary TEM to occur is debated [61,62,63]. Once at the
site of inflammation, the ability of neutrophils to remain
metabolically competent in low oxygen inflammatory environments is dependent upon the induction of the glycolytic pathway
directly regulated by HIF1a [64]. In the absence of HIF1a and
oxygen, neutrophils cannot maintain high ATP levels and as a
consequence, undergo apoptosis [65]. The delay in the timedependent recruitment of neutrophils and/or their apoptosis is
partially responsible for the increased occurrence of conidial
germination in the HIFC mice [9]. The HIFC A. fumigatus
challenged mice also had decreased levels of CD11b+Ly6G2
inflammatory monocyte-like cells, which have recently been
implicated in inflammatory conditioning for neutrophil functions
in the lung and conidial killing [41], and are also likely involved in
the HIFC phenotype.
The effects of myeloid HIF1a loss on effector cell recruitment
and survival appear to be driven in part by defects in the
production of pro-inflammatory cytokines. Though our data
strongly support a major role for the neutrophil chemoattractant
CXCL1 in mediating the HIFC phenotype, other neutrophil
chemoattractants/receptors that are known to be involved in
neutrophil recruitment during various lung infections may be
involved in the HIF1a phenotype including CCL3-CCL6-/CCR1
[66], C5a/C5aR [67], and LTB4/LTB4R1 [68,69]. However,
production of the other CXCR2 ligands CXCL2 [53] and
CXCL5 [54] that are known to have roles in neutrophil
recruitment were not different within the BALF of WT and HIFC
mice. Untangling the signal transduction cascades mediated by
HIF1a, including how it is activated in response to A. fumigatus
challenge, is an important future direction of this research.
Downstream of pathogen recognition, regulation of CXCL1
transcription through NFkB is a known mechanism for CXCL1
induction in response to inflammation [70]. Given the dual
regulation of multiple genes by HIF1a and NFkB, it is perhaps not
PLOS Pathogens | www.plospathogens.org

surprising that a role for HIF1a in CXCL1 regulation exists. Loss
of CXCL1 mRNA levels in HIF1a macrophages and the presence
of putative HREs in the CXCL1 promoter further support a direct
role for HIF1a in control of CXCL1 murine lung levels in
response to A. fumigatus challenge. Importantly, it appears that in
the context of lung infection that HIF1a may play a more
dominant role in myeloid activation of CXCL1 and the
amplification of the response. This is based on previous
demonstration that amplification of CXCL1 levels occurred only
in epithelial cells that had constitutively active HIF1a over NFkB
activation alone [71]. Given the decrease in IL-1 family members
in the HIFC mice, we hypothesize that IL-1 signaling may be play
a critical function in these signal transduction cascades. Considering that transgenic expression of CXCL1 during the course of
infection improved fungal burden and survival during infection
with A. fumigatus [55], understanding the exact mechanism for
HIF1a regulation of CXCL1 is of great importance.
Another important future direction is the cell compartment
primarily producing CXCL1 and the effects of paracrine and
autocrine signaling to regulate the observed effector cell phenotypes. Due to the ability of CXCL1 to reduce the apoptotic
phenotype of the HIFC neutrophils, we hypothesize that the HIFinduced CXCL1 responses are not only required for chemotaxis of
neutrophils, but also partially involved in inhibiting apoptosis
during infection, perhaps consistent with the known angiogenic
responses autocrine CXCL1 signaling has in epithelial cells
[72,73]. Recently, the implication for the requirement of
neutrophil transmigration in the transcriptional imprinting of
epithelial cells was demonstrated [74]. At the sites of transmigration, the depletion of oxygen by neutrophils in response to either a
pathogen or tissue injury, resulted in the stabilization of HIF1a,
which was required for mucosal protection and inflammatory
resolution [74]. In addition, the release and sensing of VEGF in an
autocrine and paracrine manner by monocytes, keratinocytes, and
endothelial cells is required for wound healing responses to restore
proper tissue homeostasis [75]. Tumors are notorious for
exploiting this mechanism to aid in their growth and metastasis,
as demonstrated by increased tumor growth with the paracrine
signaling of CXCL1 in breast cancer [76]. The increased survival
of the HIFC neutrophils with exogenous CXCL1 supports the
possibility that decreases in cytokine production in the HIFC mice
is due to decreased paracrine signaling responses between the
deficient and less abundant myeloid cells and the epithelia/
endothelia of the lung.
A direct translational outcome from our study that warrants
further investigation is the observation that corticosteroids reduced
nuclear localization and gene regulation of HIF1a. Given the
phenotype of the HIFC mice, it stands to reason that steroid
mediated suppression of HIF1a could contribute to aspergillosis
susceptibility. Our results demonstrate that steroid treatment does
not inhibit overall HIF1a protein levels, but rather reduces the
nuclear levels of HIF1a and p65 NFkB. The decrease in nuclear
p65 NFkB and subsequent HIF1a mRNA abundance did not
cause a decrease in HIF1a protein accumulation in the cytoplasm,
indicating that there may be a separate corticosteroid induced
NFkB-independent mechanism that hinders the HIF1a induced
response to A. fumigatus. Nuclear import of HIF1a is known to
rely upon interactions with the septin SEPT9_i1, a product of
transcript SEPT9_v1 that encodes isoform1, and importin-a [77].
These interactions have been established in the context of tumor
and cancer progression, but the interactions during steroid
treatment are unknown to our knowledge, and a mechanism for
the steroid blockage of HIF1a cytoplasm-nuclear localization is
not yet understood. There may also be differential posttransla11
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inoculation. For the immunocompetent experiments, mice 10–12
weeks old with targeted myeloid deletions of HIF1a created via
crosses into a background of lysozyme M–driven cre (HIFC)
expression and littermate controls (cre-/HIF1a floxed) were used
as described in [22]. For infections, mice were lightly anesthetized
and immobilized in an upright position using rubber bands
attached to a Plexiglas stand for oropharyngeal aspiration. A blunt
20G needle attached to a 1 ml syringe was advanced into the
trachea to deliver the indicated number of conidia (3–76107) in a
volume of 0.05 ml PBS or PBS with 0.025% Tween-20.

tional regulation of HIF1a under corticosteroid conditions that is
impacting the localization, interactions, and nuclear stability of
HIF1a in myeloid cells. Interestingly, corticosteroid treated mice
were demonstrated to have a two-fold reduction in CXCL1
production compared to immune competent mice following A.
fumigatus challenge [78] further supporting a role for HIF1a in
steroid induced IPA susceptibility.
Taken together, our data support the conclusion that myeloid
derived HIF1a is required by effector cells of the innate immune
system to prevent A. fumigatus pulmonary infection. As control of
metabolism and production of energy in inflammatory, low
oxygen infection sites is dependent upon HIF1a, it is in accord
that innate inflammatory responses required for clearing and
preventing infection are also tied to this important transcriptional
regulator. It will be of translational importance to determine if this
idea is reflected in the mechanisms underlying the susceptibility of
certain patients to A. fumigatus infection. Consequently, it is a
high priority to determine if this response can be targeted to
reverse the inactive and suppressed effects of the innate cells
during IPA in the context of corticosteroid mediated immune
suppression. The success of HIF1a agonists in the context of
bacterial skin infections is promising in this regard [23,25,79].

Western analysis
Nuclear and cytoplasmic proteins were isolated from lyophilized
lung tissue, BMDMs, or J774.1 macrophages at indicated times.
Cells were centrifuged at 1500 rpm for 5 min at 4uC. Supernatant
was removed, and the pellet was washed with 5 packed cell
volumes (PCV) of buffer A [10 mM Tris-HCl (pH 7.5), 1.5 mM
MgCl2, 10 mM KCl supplemented with 1M dithiothreitol, 0.2 M
PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mg/ml pepstatin, and 0.5 M Na3VO4], resuspended in 4 PCV of buffer A
and incubated on ice for 10 min. The cell suspension and lung
tissue were homogenized, and nuclei were pelleted by centrifugation at 10,000 g for 10 min at 4uC and the supernatant was
collected as the cytoplasmic fraction. The cell pellet was
resuspended in 3 PCV of buffer C [20 mM Tris-HCl (pH 7.5),
0.42 M KCl, 1.5 mM MgCl2, and 20% glycerol] and rotated for
30 min at 4uC. The suspension was centrifuged at 20,000 g for
10 min at 4uC. The protein concentration was determined using
the Bradford method (Bio-Rad, Hercules, CA, USA). Nuclear and
cytoplasmic samples were suspended in 66 SDS sample buffer,
boiled for 10 min, and loaded onto a 10% mini-protein precast
gels (Bio-Rad) for SDS-PAGE. After gel electrophoresis, protein
was transferred to a PVDF membrane using the trans-blot turbo
transfer system (Bio-Rad). HIF1a and NFkB (p65) were detected
using polyclonal rabbit anti-mouse antibodies NB100-449 (1:3000)
and C-20:sc-372 (1:1200), respectively and an anti-rabbit HRPconjugated secondary antibody raised in goat (millipore) at a
1:5000 dilution. Chemiluminescence was measured following
incubation of blots with Clarity Western ECL substrate (BioRad) using a FluorChem FC2 imager (Alpha Innotech). For
loading controls, anti-tubulin (Sigma, T5192) (human) was
utilized.

Materials and Methods
Fungal culture and growth conditions
Aspergillus fumigatus strain CBS144.89 (also known as CEA10)
was used in all experiments except those involving the FLARE
tdtomato strain generated from CEA17 (uracil auxotroph derived
from CEA10). All strains were grown on glucose minimal medium
with 1.5% agar at 37uC. Conidia were dislodged from plates with
a cell scrapper, re-suspended in 0.01% Tween-20, and filtered
through miracloth (EMD chemicals, CalBiochem).

FLARE strain generation
A. fumigatus strain CEA17 was transformed with a construct
consisting of an overlap PCR of the gpdA promoter driventdtomato from pSK536 (gift from Dr. Sven Krappmann) with A.
parasiticus pyrG. The construct was ectopically inserted into the
genome using the standard fungal protoplast transformation as
previously described [80]. Transformants were initially screened
by microscopy and flow cytometry for tdtomato expression. One
of five transformants were selected for further use, based on bright
fluorescence in all growth stages, comparable radial growth to
parental strain, and comparable inflammatory TNF responses by
BMDMs (Figure S3). Copy number was confirmed by Southern
analysis with the digoxigenin labeling system (Roche Molecular
Biochemicals, Mannheim, Germany) as previously described [81].
Generation of FLARE was done as previously described in [40]
using Biotin conjugated AF633-streptavidin or Biotin conjugated
BilliantViolet421-streptavidin (BV421) (BioLegend). For conidial
kill assays, 2.56105 FLARE conidia were incubated in 0.2 ml
RP10 with 0–10 M H2O2 for 30 min at 37uC, washed, and
analyzed by flow cytometry for TdTomato and BV421 fluorescence. Duplicate samples were plated (at 1:1,000 dilution) to
determine the cfu.

Real-time RT-PCR
Tissue or BMDMs were re-suspended in Trizol reagent and
chloroform to extract RNA. RNA was DNase treated with DNAfree kit (Ambion) and reverse transcribed with QuantiTect reverse
transcription kit (Qiagen, USA). Primers for all murine genes of
interest were designed with PrimerQuest (IDT) and manufactured
by IDT, USA. Sequences are: hif1a fwd: ATGAGATGAAGGCACAGA, rev: CACGTTATCAGAAATGTAAACC, cxcl1 (kc)
fwd: TGCACCCAAACCGAAGTCAT, rev: TTGTCAGAAGCCAGCGTTCAC, cxcr2 fwd: TGGCCTAGTCAGTCATCA,
rev: CAATCCACCTACTCCCATTC, tlr4 fwd: GTGTGTGTGTGTGTGTTG, rev: AGCTGCTCTGTACACTATTT,
dectin1 (clec7a) fwd: CCTAGTGTGATCTGTCTTGT, rev:
TTTCTGCCCACATATTGATTAG, hprt fwd: GGAGTCCTGTTGATGTTGCCAGTA, rev: GGGACGCAGCAACTGACATTTCTA, rpl13a fwd: CTCTGGAGGAGAAACGGAAGGAAA, rev: GGTCTTGAGGACCTCTGTGAACTT.
All reactions were performed on BioRad MyIQ real-time PCR
detection system with IQ SYBR green supermix (Bio-Rad,
Hercules, CA). The DDCt method was used to assess changes in
mRNA abundance, using either hprt or rpl13a as the housekeep-

Murine models of invasive pulmonary aspergillosis
CD1 female mice, 6–8 weeks old were used in the corticosteroid
(triamcinolone acetate, Kenalog) experiments. Mice were obtained
from Charles River Laboratories (Raleigh, NC). For the corticosteroid model, mice were immunosuppressed with a single dose of
Kenalog (Bristol-Myers Squibb Company, Princeton, NJ, USA)
injected subcutaneously (s.c.) at 40 mg/kg 1 day prior to
PLOS Pathogens | www.plospathogens.org
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CD45.2 (clone 104), and anti-Ly6B.2 (clone 7/4). PE- and APClabeled Abs were omitted in FLARE experiments. Neutrophils
were identified as CD45+CD11b+Ly6CloLy6G+Ly6B.2+ cells.
Flow cytometry data were collected on a BD LSR II flow
cytometer or MACSQuant 10 (Miltenyi Biotec) and analyzed with
FlowJo, v.9.4.3 (TreeStar).

ing gene. Results presented are the mean and standard deviation
from 3 biological and 3 technical replicates.

Analysis of A. fumigatus challenged mice
A. fumigatus challenged mice were euthanized at indicated
times. For histological studies, the lungs were inflated with 10%
buffered formalin, fixed, and embedded in paraffin to generate
4 mm sections stained with hematoxylin and eosin (H&E) or
Gomori’s Methenamine Silver (GMS) stain for microscopy by the
Dartmouth Immunology COBRE core facility or at Montana
State University. Contiguous tissue sections were imaged using a
Zeiss Axioscope 2-plus microscope and imaging system (Zeiss,
Jena, Germany) and a Leica upright DMRXA2 with Leica
application suite software and DC500 camera (Leica Microsystems, Buffalo Grove, IL, US). Pathological examination was
conducted for apoptosis, necrosis, and vasculature observation.
Image analysis was performed using ImageJ software (v.1.46i).
For immunohistological studies, the left lung of each mouse was
filled with OCT (frozen tissue matrix) and after embedding in
OCT immediately frozen in liquid nitrogen. The lungs were
stained as previously described in [21,82] with a rabbit polyclonal
antibody to Aspergillus (Abcam Inc., Cambridge, MA, USA) and
detected with AlexaFluor488-conjugated goat Anti-rabbit (Invitrogen, Carlsbad, CA, USA) diluted 1:400. After another washing
step, prolong Gold antifade reagent with DAPI (Invitrogen,
Carlsbad, CA, USA) was added to each section. Microscopic
examinations were performed on a Zeiss Axioscope 2-plus
microscope and imaging system (Zeiss, Jena, Germany). For each
time point, a total of 2 to 4 mice were examined and experiments
were repeated in triplicate.
To assess fungal burden in lungs, mice were sacrificed at 24, 36,
or 48 hrs post inoculation, and lungs were harvested and
immediately frozen in liquid nitrogen. Samples were freeze-dried,
homogenized with glass beads on a Mini- Beadbeater (BioSpec
Products, Inc., Bartlesville, OK, USA), and DNA extracted with
the E.N.Z.A. fungal DNA kit (Omega Bio- Tek, Norcross, GA,
USA) or phenol chloroform extraction. Quantitative PCR was
performed as described previously [39].
Cellularity was analyzed on cells from the BALF at specific time
points of 4, 8, or 12 hrs. Cells isolated from BALFs were
enumerated and stained with the following Abs: anti-CD11b
(clone M1/70), anti-CD11c (clone N418), and anti-Ly6G (clone
1A8) in staining buffer (PBS supplemented with 2% FBS).
Neutrophils were identified as CD11b+CD11c2Ly6Ghi, macrophages as CD11c+CD11b2Ly6G2, and inflammatory monocytelike cells as CD11b+CD11c2Ly6Glo (negative for NK1.1 staining,
data not shown). A fourth population of cells staining with
CD11c+CD11b+Ly6G+ were found, but further determination was
not pursued. Flow cytometry data were collected on a MACSQuant 10 (Miltenyi Biotec) and analyzed with FlowJo, v.9.4.3
(TreeStar).
To assess the requirement of CXCL1 for in vivo infection,
HIFC mice received 50 mL of 50 ng recombinant CXCL1
(BioLegend) 4 hrs following inoculation of 76107 conidia and
were compared to HIFC mice and WT infected mock mice
receiving PBS. Separate experiments analyzing survival, cell
recruitment by flow cytometry, and fungal burden were conducted.
Single-cell lung suspensions were prepared for flow cytometric
analysis and classified as described in Hohl et al. (2009). Tissue
processing did not result in leukocyte uptake of exogenously added
FLARE conidia. Lung digest and, if applicable, BALF cells were
enumerated and stained with the following Abs: anti-Ly6C (clone
AL-21) anti-Ly6G (clone 1A8), anti-CD11b (clone M1/70), antiPLOS Pathogens | www.plospathogens.org

LDH and Albumin assays
Lactate dehydrogenase (LDH) using the CytoTox96 nonradioactive cytotoxicity assay kit (Promega, Cat. No. 573702)
and albumin assay (Albumin (BCG) Reagent Set, Eagle Diagnostics, Cedar Hill, TX, USA) were conducted on BALFs from WT
and HIFC mice inoculated with 76107 conidia or PBS according
to manufacturers instructions with slight variation. Briefly, 100 mL
of the BALF was added to equal volumes of the respective agents
and incubated for either 30 min (LDH) or 5 min (Albumin) and
read at 490 nm and 630 nm, respectively. Albumin levels were
determined using a standard curve and LDH values for each time
point are relative to the WT PBS BALF sample.

Bone-marrow derived cells
Bone marrow (BM) cells were eluted from tibias and femurs of
8–12 week old Littermate or HIFC mice, lysed of red blood cells,
and cultured for macrophages in RP20 (RPMI, 20% FCS, 5 mM
HEPES buffer, 1.1 mM L-glutamine, 0.5 U/ml penicillin, and
50 mg/ml streptomycin) supplemented with 30% (v/v) L929 cell
supernatant (source of M-CSF) or neutrophils in murine neutrophil buffer (HBSS containing 0.1% FBS and 1% glucose). BM cells
for macrophages were plated in a volume of 20 ml at a density of
2.56106 cells/ml in 10 ml petri dishes. The medium was
exchanged on day 3. Adherent BM-derived macrophages
(BMDMs) were harvested on day 6. BM- derived cells for
neutrophils (BMDNs) were suspended in 3 ml 45% percoll and
isolated from a 30 min 16006 g percoll gradient (top to bottom:
3 ml 45% percoll containing BM cells, 2 ml 50%, 2 ml 55%, 2 ml
62%, and 3 ml 81%) in a Sorvall Legend Mach 1.6R benchtop
centrifuge, with a BIOshield 600 rotor-75002005 (Thermo
Scientific). BMDNs were collected from the 62/81% border and
washed with HBSS before live cell counting (95% purity,
determined by cytospin). For the cytokine mRNA abundance
quantifying experiments, BMDMs were incubated with A.
fumigatus conidia (strain CBS144.89) in a 10:1 (effector:target)
ratio 8 hrs. Following the incubation, cells were directly resuspended in Trizol reagent and chloroform to extract RNA for
qRT-PCR.

CFU and XTT assays
BMDMs were incubated with A. fumigatus conidia in a 9:1
(effector:target) ratio 3 hrs (for CFU) and 16 hrs (for XTT).
Following the 3 hr incubation, non-phagocytosed conidia were
washed off the cells, serially diluted onto GMM plates in duplicate,
and CFU was determined. Following the 16 hr incubation,
BMDMs were cold water lysed and the percent damage was
quantitated by measuring the OD at 450 nm following a 1 hr
incubation with XTT as previously described [82].

Cytokine analysis
Collected BALFs were assayed by ELISA and luminex.
Commercially available ELISA kits for CXCL1 (Assay Biotech,
OK-0189), CXCL2 (R&D systems, DY452), and CXCL5 (R&D
Systems, DY443) were used according to the manufactures’
instructions. The limit of detection was 15 pg/ml. Luminex
analysis was carried out using Bio-Plex Pro Mouse Cytokine
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neutrophils with pyknotic nuclei and karyorrhexis out of the total
number of neutrophils per frame. Ruffled neutrophils were also
quantified and depicted neutrophil activation. Ten random frames
at 8 hrs post challenge were analyzed from four HIFC and four
WT mice (analyzed two separate experiments).

immunoassay on a Bio-Plex Array Reader (Bio-Rad Laboratories
Inc., Hercules, CA) according to the manufactures’ instructions.
Bio-Plex Manager software with five-parametric-curve fitting was
used for data analysis and procedure was carried out by the
Dartmouth Immunology COBRE core. For BMDM cytokine
analysis of TdTomato strain, cells were washed and plated in
0.2 ml TC medium at a density of 56105 cells/ml in 96 well plates
and co-incubated in a 9:1 ratio with conidia for 8 hrs.
Supernatants were collected for ELISA. A commercially available
ELISA kit for TNF (eBioscience, San Diego, California, US) was
used according to the manufactures’ instructions. The limit of
detection was 15 pg/ml for TNF.

Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
animal experimental protocol was approved by the Institutional
Animal Care and Use Committee (IACUC) at Dartmouth College
(protocol number cram.ra.1).

Migration assay
BMDN migration was examined using Costar Transwell plates
(6.5 mm diameter insert, 3.0 mm pore size, polycarbonate
membrane, Corning Inc., Corning, NY). To determine if
migration was defective, 10% FBS was added to the bottom
chamber of these plates (media without FBS was used as a
migration control). Isolated BMDNs were counted using trypan
blue (Sigma), then placed in serum free medium (SFM). Cells were
resuspended at 16106/ml SFM and 250 ml were allowed to
migrate for 3 hr at 37uC at 5% CO2. Following migration, the
medium in the top chamber was aspirated and the membrane
gently wiped with a cotton swab to remove the cells that did not
migrate. The membranes were first rinsed with PBS, the cells were
then fixed with 2% formaldehyde in PBS, permeabilized with
0.01% Triton X-100 (Sigma) in PBS and finally stained with
crystal violet (Sigma). Cells that migrated across the membrane
were counted. Ten random fields at 406 were counted for each
condition using light microscopy. Each experiment was repeated
three times. Results are expressed as mean cell migration
normalized to media control 6 SEM. To determine the role for
cytokine signaling in migration defects, a BALF-switch experiment
using BALFs from infected HIFC and littermate mice in the
bottom chamber was conducted. Briefly, 250 ml BMDNs at
16106/ml SFM were added to the top chamber of a transwell
plate with FN coated membranes with 300 ml of BALF in the
bottom chamber and were allowed to migrate for 3 hr at 37uC and
5% CO2. For add-back experiments, recombinant CXCL1
(Biolegend) was added back to the BALFs from infected HIFC
mice to the concentration determined by ELISA in the infected
littermate BALFs (600 pg).

Supporting Information
Figure S1 Analysis of HIF1a protein abundance in
J774.1 macrophages and in macrophages from mice
deficient in myeloid HIF1a. A) Nuclear protein abundance of
HIF1a from J774.1 macrophages incubated with A. fumigatus
conidia, germlings, hyphae, or nothing for 6 hrs in normoxic
conditions. B) Protein abundance of HIF and NFkB p65 subunit
in the cytoplasmic and nuclear extracts from WT and HIFC
BMDMs incubated with and without conidia (10:1 ratio) for 8 hrs.
Bar graph depicting quantitation of the band densities for HIF and
p65 following normalization to c-tubulin (c-tub).
(TIFF)
Figure S2 Histology and immunohistochemistry of
HIFC and WT mice (to go with Fig. 2). Immune competent
littermate (WT) and HIFC mice received 76107 conidia i.t. (A)
Representative histology of H&E or GMS stained lung sections
from HIFC and WT mice at 8 hr post challenge. Left image (56),
right image (206). (B) Representative immunohistochemistry of
WT and HIFC mice 5 mm frozen lung sections stained with antiaspergillus (green) and DAPI (blue) at 24 and 48 hr post challenge.
All images are 206.
(TIFF)
Figure S3 FACs analysis, TNF stimulation, and viability
test of CEA10 FLARE strain. FACs analysis demonstrating the
different components and scatter profiles of the FLARE
construction: Conidia from CEA10 WT strain (A), CEA10 strain
with biotin conjugated BV421-SA (B), TdTomato CEA10 strain
(C), and TdTomato strain with biotin conjugated BV421-SA
(FLARE) (D). FACs plots are BrilliantViolet (y-axis) vs. TdTomato
(x-axis). (E) ELISA for TNF protein on supernatants from WT
BMDM’s incubated with TdTomato and CEA10 conidia for 8 hr.
(F) The graph shows TdTomato (squares) and BV421 (triangles)
fluorescence and cfu (circles) from FLARE conidia exposed to the
indicated H2O2 concentration demonstrating the TdTomato
instability and BV421 stability when encountering oxidative stress.
Mean fluorescence intensity is indicated relative to FLARE
conidia not treated with H2O2.
(TIF)

Neutrophil apoptosis
Neutrophil apoptosis was measured using FACs analysis by
staining BMDN’s incubated at 37u, 5% CO2 in RP20 medium
with annexin V-Pacific Blue (PB) (BioLegend, #640917) and PI
(millipore). Staining was performed by following the manufacturer’s instructions, with minor changes. Briefly, after isolation or
incubation for the specified time points, neutrophils were washed
twice with ice-cold PBS with 2% FBS and then resuspended in
Annexin-V binding buffer (0.01 M HEPES, pH 7.4; 140 mM
NaCl; 2.5 mM CaCl2). Annexin V-PB and PI were added into the
culture tube and incubated for 15 min prior to direct analysis with
flow cytometry. Viable neutrophils were defined as negative for
annexin V-PB and PI staining; apoptotic neutrophils were defined
as positive for annexin V-PB staining but negative for PI staining.
Cells positive for both annexin V-PB and PI staining were
considered necrotic cells. Cell survival/apoptosis was expressed as
a percentage of neutrophils relative to the total number of counted
neutrophils. In vivo neutrophils were quantified through analysis
of BALF cytospins as previously described [45,46,47]. Briefly,
apoptotic neutrophils were visualized by counting the number of
PLOS Pathogens | www.plospathogens.org

Figure S4 Flow cytometry dot plot to go with Fig. 7.

Representative FACs analysis of cell recruitment (same staining
and gating strategy as in Figure 4) at 8 hrs post challenge using
CD11b, Ly6G, and CD11c fluorescent antibodies for staining of
cells in the lung BALF of WT, HIFC, and HIFC mice infected with
76107 conidia and treated with PBS or 50 ng rCXCL1 4 hr post
conidial challenge. Main plots are CD11b v. CD11c and
expanded cell population gate I plot is CD11b v. Ly6G.
(TIF)
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Figure S5 Putative HIF1a binding sites in CXCL1
promoter and PRR expression profiles on neutrophils.
(A) Nucleotide sequence from the mouse CXCL1/KC gene
containing the 50flanking region with ,480 nucelotides from the
indicated transcriptional start site [70,83]. Known NFkB and
putative HIF1a binding motifs are indicated in the promoter
region. (B) WT and HIFC BMDNs were incubated with A.
fumigatus conidia in a 10:1 ratio for 3.5 hrs. mRNA abundance of
cxcr2, tlr4, and dectin1 was determined using quantitative RTPCR, normalized to rpl13a, and relative to the WT sample (2
biological and 3 technical replicates).
(TIFF)
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